This study will evaluate the effectiveness and dose-response of a drug, atacicept, in reducing high levels of protein in urine (proteinuria). Atacicept will be compared to placebo (a sugar pill with no active drug) in participants with IgAN (immunoglobulin A nephropathy) and persistent proteinuria.
| Study Type: | Clinical Trial |
| Clinical Area: | Nephrology |
| Condition: | Berger's disease |
| Principal Investigator: | Professor John Holian |
| Study Coordinator: | Elaine Gilroy |
| Key Eligibility Criteria: | Age 18 years. Diagnosis of IgAN as demonstrated by renal biopsy |
| Contact Email: | elainegilroy@svhg.ie |